Vaccine, 41(1), 251. Elsevier Willame, C, Dodd, C, Durán, C E, Elbers, R J H J, Gini, R, Bartolini, C, Paoletti, O, Wang, L, Ehrenstein, V, Kahlert, J, Haug, U, Schink, T, Diez-Domingo, J, Mira-Iglesias, A, Carreras, J J, Vergara-Hernández, C, Giaquinto, C, Barbieri, E, Stona, L, Huerta, C, Martín-Pérez, M, García-Poza, P, de Burgos, A, Martínez-González, M, Bryant, V, Villalobos, F, Pallejà-Millán, M, Aragón, M, Souverein, P, Thurin, N H, Weibel, D, Klungel, O H & Sturkenboom, M C J M 2023, ' Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases-an ACCESS cohort study ', Vaccine, vol. 41, no. 1, pp. 251-262 . https://doi.org/10.1016/j.vaccine.2022.11.031 Vaccine, 41(1):251-262
Drug Safety, 45(10), 1305-1306. Adis International Ltd Riera-Arnau, J, Bots, S, Belitser, S, Messina, D, Schultze, A, Douglas, I, Duran, C, Poza, P G, Gini, R, Herings, R M C, Sisay, M M, Martin, I, Villalobos, F, Klungel, O H & Sturkenboom, M 2022, ' Association between SARS-CoV-2 Vaccines and Myo-and Pericarditis; a Large Observational Study Using Electronic Healthcare Data from Four European Countries ', Drug Safety, vol. 45, no. 10, pp. 1305-1306 .